Ranok Therapeutics
PrivateLast Round
Series B
Aug 18, 2021
Total Funding Raised
$40M
Company Overview
Ranok Therapeutics operates in Healthcare & Life Sciences and is based in Hangzhou. Its latest recorded funding round was a Series B round in August 2021.
Ranok Therapeutics is a drug discovery company that develops an innovative targeted protein degradation technology for the discovery and development of novel therapeutics.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Ranok Therapeutics Comparables
Compare Ranok Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| HealZen Therapeutics Co., Ltd. | 87% | |
| Plexium | 84% | |
| Cullgen | 84% |
For institutional investors. Book with your work email.
Ranok Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Aug 18, 2021 | ||||
| Seed | Mar 27, 2020 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Ranok Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Shanghai Healthcare Capital | Series B |
| Wu Capital | Series B |
| Lapam Capital | Series B |
Ranok Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Ranok Therapeutics's valuation, stock price, and market status.
Is Ranok Therapeutics a public or private company?
Ranok Therapeutics is a private company.
What is the current stock price of Ranok Therapeutics?
Ranok Therapeutics is a private company, so its shares have no public market price. Caplight tracks Ranok Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Ranok Therapeutics worth (valuation)?
Valuation information for Ranok Therapeutics is not publicly available.
Can I buy Ranok Therapeutics stock?
Ranok Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Ranok Therapeutics's last funding round?
Ranok Therapeutics's most recent funding round was Series B on August 18, 2021.
Who are the main investors in Ranok Therapeutics?
Key investors in Ranok Therapeutics include Shanghai Healthcare Capital, Lapam Capital.
Will Ranok Therapeutics IPO soon?
No public IPO plans have been announced for Ranok Therapeutics.
How can I track Ranok Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in Ranok Therapeutics's shares on secondary markets.